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Abstract 
 
Lactams are an important class of heterocyclic compounds and are widely used for industrial 
and pharmaceutical purposes. Even decades after initial lactam syntheses, research on their 
physical and chemical properties is still rewarding. It delivers valuable information on the 
reactivity of lactams and their conformational behavior. For the small and medium-sized parent 
lactams the X-ray structures have been well known, except for the ‘missing link’ the 6-
membered valerolactam. An X-ray structure of valerolactam is described here for the first time 
stimulating a comparative discussion of the homologous lactam series. The experimental solid 
state conformation of valerolactam differs significantly from the calculated and energy-
minimized ones reported in the literature. The amide bond length in valerolactam is more or 
less equal to other lactams. A comparison with the structure of cyclohexene revealed striking 
similarities arising from the partial C-N double bond in valerolactam caused by amide 
resonance.  
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INTRODUCTION 
 
Lactams, i.e. cyclic amides, are an important class of heterocyclic compounds. By means of 
nomenclature they are sometimes considered as oxo derivatives of the respective cyclic amines. 
More common are their trivial names derived from the root of the respective carboxylic acid, 
e.g. the lactam containing seven carbon atoms is named enantholactam after enanthic acid 
(=heptanoic acid) (Figure 1). One of the oldest and best described lactams is the 7-membered 
cycle, i.e. caprolactam, caprolactam, which was described in the 19th century.1 Additional 
members of the homologous series gained more and more significance.  
 
 
 
Figure 1. Nomenclature of small and medium-sized 
lactams (trivial names). 
 
Lactams and their derivatives are widely used in industry,2,3 occur in natural products 
chemistry,4 and are employed as active pharmaceutical ingredients (APIs) with the β-lactam 
antibiotics as the most prominent examples.5 Insight into their reactivity, thermodynamic and 
kinetic stability as well as their conformational behavior has provided crucial knowledge for 
biology and materials science based applications. As observed for non-cyclic amides, lactams 
possess a resonance stabilized C-N bond with partial double bond character, which goes in 
hand with resonance stabilization. For butyro-, valero- and enantholactam it was reported that 
the C-N double bond character is very similar resulting in comparable stability towards 
hydrolysis.6 Another typical property of lactams is the existence of cis and trans forms resulting 
from different dihedral angles of the amide bond.7,8  
During our studies on bridged lactams9 we became interested in the conformation and solid 
state behavior of small and medium-sized lactams. For the underivatized lactams with ring 
sizes 4-10 the X-ray structures have been well known, except for the ‘missing link’ the 6-
membered valerolactam (1). Valerolactam has been suggested as a system to mimic the base 
pairing in nucleic acids.10 Moreover, 1 is a valuable precursor for the total synthesis of different 
natural products11-14 and is frequently employed in the development of chemical 
methodologies.15-17 Additionally, several bioactive compounds are valerolactam derivatives.18-
22 Only recently, the biotechnological production of valerolactam (1)23 and a lactam biosensor24 
have been introduced. So far, the molecular structure of 1 has only been described in respective 
co-crystals25-31 and metal complexes.32-36 Here, we describe for the first time a crystal structure 
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4 
of valerolactam (1) in the absence of other ligands, completing a homologous structural series 
of small and medium-sized lactams.  
After some difficulties we were able to determine the molecular structure of 1 from 
commercially available valerolactam. Although the purchased compound exhibits seemingly 
well-formed crystals, the determination of its X-ray structure proved rather difficult due to 
apparent hygroscopicity combined with the low melting point of the substance (38-40 °C).37 
When taken out of the bottle, the crystals very quickly were dissolved (Figure 2) and gave only 
unsatisfying data (1a in ESI). In order to cool the crystals and prevent interaction with humidity 
we used a handmade cooling set-up (Figure S1, ESI), which finally facilitated the selection, 
measurement and structure determination of 1 (Table S1, ESI). 
 
 
 
Figure 2. Images of valerolactam (1) exposed to air at room 
temperature on a microscope taken at different times.  
 
Valerolactam (1) crystallizes in the monoclinic space group P21/c with one molecule in the 
asymmetric unit or triclinic space group P-1 (1a in ESI, Figure S2). In 1, the C-C bond lengths 
range from 1.5108(16) to 1.5225(16) Å. (The estimated standard deviations, esds, are given in 
brackets.) The experimental length of the amide bond [1.3344(16) Å] is somewhat shorter than 
the calculated one (1.372 Å).38 The valerolactam molecule in co-crystals and crystalline metal 
complexes were found to have a somewhat shorter amide bond (Table S2 and S3, ESI). The 
amide region of valerolactam can be considered as planar [3.21(19)°], which differs 
considerably from the calculated values (MNDO calculations39: 20.4°; ab initio MO 
calculations40: -17.8 °). While additional conformations were found in the gas phase,41 in the 
X-ray structure valerolactam features a half-chair conformation similar to those found in the 
respective cycloalkene, viz. cyclohexene.42 The valerolactam atoms C2 and C3 deviate by 
0.417(2) Å and 0.325(2) Å, respectively, from the C1-N1-C5-C4 mean plane; the equivalent 
atoms in cyclohexene deviate by 0.366 Å and 0.373 Å (Table 1). In valerolactam co-crystals 
the title compound develops quite variable torsion angles, though in most cases still half-chair 
conformations are adopted (Table S2, ESI). By way of interest, in metal complexes containing 
multiple valerolactam molecules bond lengths and torsions differ over a broad range as 
exemplarily shown for octakis(δ-valerolactam-O)-neodymium triperchlorate43 (VOTKUK) 
(Table S3, ESI).  
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Table 1. Conformational parameters [°] of valerolactam (1), cyclohexenea, 42 and 
cyclohexane.b, 44  
 
    
 
  
 
  
C1-C2-C3-C4 -61.06(14) -61.2 -55.6 
C2-C3-C4-C5 44.45(15) 44.9 55.1 
C3-C4-C5-X -15.84(16) -13.9 -54.5 
C4-C5-X-C1 3.21(19) -2.05 55.6 
C5-X-C1-C2 -19.81(18) -13.6 -55.1 
X-C1-C2-C3 48.21(15) 44.3 54.5 
 
  
--- 
C2/C3 deviation 
C4-C5-X-C1 
mean plane [Å] 
0.325(2), 0.417(2) 0.366, 0.373 --- 
a The crystal structure contains two molecules; we refer to the non-disordered one. 
b The conformation for cyclohexane polymorph II at 115 K is shown.  
 
In the packing of 1 two lactam molecules are connected via strong N-H∙∙∙O hydrogen bonds 
[d(N∙∙∙O)=2.9070(14) Å] and form R2
2(8) amide dimers (Figure 3a). Double hydrogen-bonded 
valerolactam dimers have already been describe in solution.Error! Bookmark not defined. In the overall 
packing, the dimeric aggregates are interconnected via hydrophobic interactions and C-H∙∙∙O 
contacts [d(C∙∙∙O)=3.4210(17) Å] (Table 2) between C3 and the amide carbonyl; an R2
2(10) 
graph-set descriptor has been found (Figure 3b).  
 
 
Table 2. Distances and angles of hydrogen bond type interactions in the 
molecular structure of valerolactam (1) 
 
  
distances [Å] angle [°] 
atoms symmetry 
  D···A H···A D–H···A 
1     
N(1)-H(1N)∙∙∙O(1) -x, -y, -z+1 2.9070(14) 2.057(18) 176.3(15) 
C(3)-H(3B)∙∙∙O(1) -x, -y+1, -z+1 3.4210(17) 2.58 142.4 
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(a) 
 
 
(b) 
 
Figure 3. Molecular structure of valerolactam (1) (a) and 
its packing behavior (b). Hydrogen bonds (black) and C-
H∙∙∙O contacts (grey) are displayed as broken lines. 
Hydrophobic interactions are shaded.  
 
So far, the X-ray structures of propio- (FEPNAP),45 butyro- (NILYAI),46 capro- (CAPLAC),47 
enantho- (ENANOL),48 caprylo- (CAPRYL)49 and pelargolactam (PELARG)50 have been 
determined. In the following, we discuss the structure of the newly studied valerolactam in 
context of those of the other lactams, especially as it is a “missing link” between them.  
For design of new non-β-lactam lactamase inhibitors,51 it is important to know if during the 
hydrolysis of lactams the ring strain or the high carbonyl reactivity is rate-limiting. Imming 
and co-workers studied the hydrolysis of several lactams and found that the propio- and 
valerolactam are specifically labile in comparison to the others.52 They postulated that not the 
C-N bond fission, but the formation of the tetrahedral intermediate was rate-determining. This 
hypothesis is underpinned by the fact that for the 4- to 9-membered lactams the length of the 
amide bonds are more or less equal for the whole series (1.328-1.335 Å) (Table 3, Figure 4). 
(The different temperatures during structure determination are clearly a source of uncertainty.) 
By way of interest, for the 10-membered ring (pelargolactam), the amide bond is considerably 
longer (1.426 Å). To the best of our knowledge X-ray structures of higher lactams have not 
been determined yet. 
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Table 3. Conformational and bonding parameters in the discussed series of lactams 
 
       
Compound 
(CSD codes) 
FEPNAP NILYAI 1 CAPLAC ENANOL CAPRYL PELARG 
T [K] 170 173 173 295 98 295 295 
d[C(O)-NH] 
[Å] 
1.333(2) 1.335(2) 1.3344(16) 1.328(2-3) 1.334(2) 1.334(3-4) 1.426a 
Hydrolysis  
kinetics52 
k2 [M-1 s-1] 
2.37∙10-4 5.59∙10-6 1.21∙10-4 3.21∙10-6 1.36∙10-7 2.72∙10-7 -b 
C-C(O)-NH-C 
dihedral angle [°] 
0.0(2) 
(cis) 
4.3(1) 
(cis) 
3.21(19) 
(cis) 
-4.2(4) 
(cis) 
1.4(3) 
(cis) 
148.4(5) 
(trans) 
167.1a 
(trans) 
H bonding 
pattern 
R2
2(8) 
amide  
dimers +  
C(4) amide  
chains  
R2
2(8) 
amide  
dimers 
R2
2(8) 
amide  
dimer 
R2
2(8) 
amide  
dimer 
C(4) 
amide  
chains 
C(4)  
amide  
chains 
C(4)  
amide  
chains 
KPIc [%] 74.8 71.8 69.2 67.4 70.7 69.3 -d 
d(H∙∙∙A) 
d(D-H∙∙∙A) 
˂(DHA) 
2.19 
2.967 
152.8  
1.98 
2.921 
172.4 
2.057(18) 
2.9070(14) 
176.3(15) 
1.84 
2.895 
172.7 
1.94 
2.815 
172.8 
2.03 
2.864 
165.2 
-d 
2.758 
-d 
a no esd given 
b not determined in reference52 
c Kitaigorodskii packing index 
d not determined as the X-ray structure has only been resolved incompletely. 
 
 
 
Figure 4. Diagram of the amide bond lengths in connection with the 
lactam ring size. (The data for the pelargolactam, ring size=10, 
should be interpreted cautiously due to the incomplete 
crystallographic data for this particular compound.)  
 
As expected, all lactams compared here are engaged in strong N-H∙∙∙O hydrogen bonds. 
Though, depending on the ring size, two different graph-set descriptors are observed. For 5- to 
7-membered lactams, cyclic R2
2(8) interactions are preferred. For 8- to 10-membered lactams, 
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8 
C(4) chains can be found. The 4-membered propiolactam displays both, N-H∙∙∙O rings and 
chains, leading to the highest Kitaigorodskii packing index (KPI) (74.8 %) observed in this 
series.  
Figure 5 shows the distance of hydrogen bond donors (D) and acceptors (A) with respect to the 
lactam ring size. By way of interest, for lactams up to caprolactam the D∙∙∙A distances between 
the R2
2(8) dimers decrease (2.97 to 2.90 Å). In the 8-membered enantholactam displaying C(4) 
chains instead dimers, we found the shortest N-H∙∙∙O distance (2.815 Å) for all of the 
unsubstituted lactams. For larger rings the respective distances in the N-H∙∙∙O chains are 
increasing again, which may be connected with the switch from cis to trans amides in caprylo- 
and pelargolactam (Figure S3, ESI). Despite the varying D∙∙∙A distances in the N-H∙∙∙O 
hydrogen bonds, the DHA angles only differ slightly (165.2-176.3 °) except for the 4-
membered lactam (120.0 °; 152.8 °); this can be explained with the small ring size of 
propiolactam (Figure S4, ESI). Interestingly, α-chlorovalerolactam53 (CSD code: CLVALA) 
has a slightly longer amide bond than the parent compound 1 (1.365 Å) and develops C(4) 
chains [d(N∙∙∙O)=2.910 Å] as observed for enantholactam. 
 
 
 
Figure 5. H bonding donor∙∙∙acceptor distances in the molecular 
structures with reference to the lactam ring size (4-10). 
 
In conclusion, we described for the first time the X-ray structure of valerolactam, which 
stimulated a comparative discussion of the homologous series of lactams. Surprisingly, the 
amide bond length in the title compound is more or less equal to other lactams, hence, the 
different ring strains have only a minor influence on the amide length. As the kinetics for the 
hydrolysis of lactams differ for the individual lactams, the rate of lactam hydrolysis is 
determined by the formation of the tetrahedral intermediate not by the C-N bond fission. The 
experimental conformation of valerolactam in the solid state differ significantly from the 
calculated and energy-minimized ones reported in the literature. A comparison with the 
structure of cyclohexene revealed striking similarities arising from the partially C-N double 
bond in valerolactam. It would be interesting to see if this can also be translated to derivatives 
of valerolactam and cyclohexene.  
  
Page 8 of 13
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9 
EXPERIMENTAL SECTION 
 
Suitable crystals of 1 and 1a (ESI) were selected directly from a purchased bottle of 
valerolactam (Fluorochem). Single crystal X-ray diffraction was performed at 173 K with a 
Bruker D8 Venture diffractometer using a Cu-Kα source. Structure solution was carried out 
with shelxs54 and structure refinement with shelxl54 was finished using ShelXle55 software. The 
crystallographic data for the structures of 1 and 1a have been deposited with the Cambridge 
Crystallographic Data Centre; CCDC number: 1839815 (1), 1839822 (1a). 
 
 
ASSOCIATED CONTENT 
 
Supporting Information 
Selected details of the data collection and additional figures underlining the structure 
description. The Supporting Information is available free of charge on the xxx website at DOI: 
xxx 
 
 
AUTHOR INFORMATION 
 
Corresponding Author 
* Corresponding author. Tel.: +44 (0)1522 837396. 
E-mail address: tgruber@lincoln.ac.uk (T. Gruber). 
 
Notes 
The authors declare no competing financial interest. 
 
 
ACKNOWLEDGMENTS 
 
We gratefully acknowledge financial support from the School of Pharmacy, University of 
Lincoln. 
 
 
REFERENCES 
 
(1) Ritz, J.; Fuchs, H.; Kieczka, H.; Moran, W. C. “Caprolactam”, In: Ullmann's Encyclopedia of Industrial 
Chemistry, Wiley-VCH: Weinheim, Germany, 2005. 
 
(2) Puffr, R.; Kubanek, V. Lactam-based Polyamides, CRC Press: Boca Raton, USA, 1991. 
 
(3) Serpe, G.; Chaupart, N. Relaxation–structure relationship in bulk and plasticized polyamide 11. J. Polym. Sci. 
B: Polym. Phys. 1996, 34, 2351-2365. 
 
(4) Janecki, T. (Ed.) Natural Lactones and Lactams: Synthesis, Occurrence and Biological Activity, Wiley VCH: 
Weinheim, Germany, 2013. 
 
(5) Morin, R. B.; Gorman, M. (Eds.) The Biology of β-Lactam Antibiotics, Academic Press: Cambridge, USA, 
2014. 
 
(6) Assaf, Z.; Eger, E.; Vitnik, Z.; Fabian, W. M. F.; Ribitsch, D.; Guebitz, G. M.; Faber, K.; Hall, M. Identification 
and Application of Enantiocomplementary Lactamases for Vince Lactam Derivatives. ChemCatChem 2014, 6, 
2517-2521. 
Page 9 of 13
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
10 
 
(7) G. Montaudo, S. Caccamese, V. Librando, A. Recca, Structural analysis by lanthanide shift reagents: IV. 
Conformation of the amide group as a function of the ring size in lactams. J. Mol. Struct. 1975, 27, 303-308.  
 
(8) Abraham, R. J.; Filippi, M.; Petrillo, G.; Piaggio, P.; Vladiskovic, C.; Sancassan, F. A theoretical and NMR 
lanthanide-induced shift (LIS) investigation of the conformations of lactams. Magn. Reson. Chem. 2017, 55, 1059-
1072. 
 
(9) Weck, C.; Obst, F.; Nauha, E.; Schofield, C. J.; Gruber, T. Synthesis of a bicyclic oxo-γ-lactam from a simple 
caprolactam derivative. New J. Chem. 2017, 41, 9984-9989. 
 
(10) Pandey, P.; Chakraborty, T. Doubly Hydrogen Bonded Dimer of δ-Valerolactam: Infrared Spectrum and 
Intermode Coupling. J. Phys. Chem. A, 2012, 116, 8972-8979. 
 
(11) Westermann, B.; Walter, A.; Diedrichs, N. Diastereoselective Synthesis of C-Glycosylated Amino Acids 
with Lactams as Peptide Building Blocks. Angew. Chem. Int. Ed. 1999, 38, 3384-3386.  
 
(12) De Simone, F.; Gertsch, J.; Waser, J. Catalytic selective cyclizations of aminocyclopropanes: formal 
synthesis of aspidospermidine and total synthesis of goniomitine. Angew. Chem. Int. Ed. 2010, 49, 5767-5770.  
 
(13) Frei, R.; Staedler, D.; Raja, A.; Franke, R.; Sasse, F.; Gerber‐Lemaire, S.; Waser, J. Total synthesis and 
biological evaluation of jerantinine E. Angew. Chem. Int. Ed. 2013, 52, 13373-13376.  
 
(14) Nocket, A. J.; Weinreb, S. M. Total synthesis of the tetracyclic antimalarial alkaloid (±)-myrioneurinol. 
Angew. Chem. Int. Ed. 2014, 53, 14162-14165.  
 
(15) Du, Y.; Wiemer, D. F. Preparation of α-Phosphono Lactams via Electrophilic Phosphorus Reagents:  An 
Application in the Synthesis of Lactam-Based Farnesyl Transferase Inhibitors. J. Org. Chem. 2002, 67, 5709-
5717. 
 
(16) Kuhnert, N.; Clemens, I.; Walsh, R. On the activation of valerolactam with triflic anhydride: the synthesis of 
omega-trifluorosulfonamido dipeptides using a transpeptidation reaction under mild conditions. Org. Biomol. 
Chem. 2005, 3, 1694-1701.  
 
(17) Meuresch, M.; Westhues, S.; Leitner, W.; Klankermayer, J. Tailor-Made Ruthenium-Triphos Catalysts for 
the Selective Homogeneous Hydrogenation of Lactams. Angew. Chem. Int. Ed. 2016, 55, 1392-1395. 
 
(18) Munguia, B.; Mendina, P.; Espinosa, R.; Lanz, A.; Saldana, J.; Andina, M. J.; Ures, X.; Lopez, A.; Manta, 
E.; Dominguez, L. Synthesis and anthelmintic evaluation of novel valerolactam- benzimidazole hybrids. Lett. 
Drug Des. Discovery 2013, 10, 1007-1014. 
 
(19) Munguia, B.; Michelena, M.; Melian, E.; Saldana, J.; Ures, X.; Manta, E.; Dominguez, L. Development of 
novel valerolactam-benzimidazole hybrids anthelmintic derivatives: Diffusion and biotransformation studies in 
helminth parasites. Exp. Parasitol. 2015, 153, 75-80. 
 
(20) Clark, P. G.; Vieira, L. C.; Tallant, C.; Fedorov, O.; Singleton, D. C.; Rogers, C. M.; Monteiro, O. P.; Bennett, 
J. M.; Baronio, R.; Müller, S.; Daniels, D. L.; Méndez, J.; Knapp, S.; Brennan, P. E.; Dixon, D. J. LP99: Discovery 
and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angew. Chem. Int. Ed. 2015, 54, 6217-6221. 
 
(21) Chen, M.; Liu, F.; Dong, G. Direct Palladium-Catalyzed β-Arylation of Lactams. Angew. Chem. Int. Ed. 
2018, 57, 3815-3819. 
 
(22) Liu, X.; Wang, Y.; Zhang, X.; Gao, Z.; Zhang, S.; Shi, P.; Zhang, X.; Song, L.; Hendrickson, H.; Zhou, D.; 
Zheng, G. Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation. Bioorg. Med. 
Chem. 2018, 26, 3925-3938. 
 
(23) Zhang, J.; Barajas, J. F.; Burdu, M.; Wang, G.; Baidoo, E. E.; Keasling, J. D. Application of an Acyl-CoA 
Ligase from Streptomyces aizunensis for Lactam Biosynthesis. ACS Synth. Biol. 2017, 6, 884-890.  
 
Page 10 of 13
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
11 
(24) Zhang, J.; Barajas, J. F.; Burdu, M.; Ruegg, T. L.; Dias, B.; Keasling, J. D. Development of a Transcription 
Factor-Based Lactam Biosensor. ACS Synth. Biol. 2017, 6, 439-445.  
 
(25) Gotoh, K.; Ishida, H. Hydrogen-bonded structures of the 1:1 and 1:2 compounds of chloranilic acid with 
pyrrolidin-2-one and piperidin-2-one. Acta Crystallogr. 2011, C67, o500-o504. 
 
(26) Moragues-Bartolome, A. M.; Jones, W.; Cruz-Cabeza, A. J. Synthon preferences in cocrystals of cis-
carboxamides:carboxylic acids. CrystEngComm, 2012, 14, 2552-2559. 
 
(27) Bolla, G.; Mittapalli, S.; Nangia, A. Celecoxib cocrystal polymorphs with cyclic amides: synthons of a 
sulfonamide drug with carboxamide coformers. CrystEngComm 2014, 16, 24-27. 
 
(28) Bolla, G.; Nangia, A. Multicomponent ternary cocrystals of the sulfonamide group with pyridine-amides and 
lactams. Chem. Commun. 2015, 51, 15578-15581. 
 
(29) Bolla, G.; Mittapalli, S.; Nangia, A. Modularity and three-dimensional isostructurality of novel synthons in 
sulfonamide-lactam cocrystals. IUCrJ, 2015, 2, 389-401. 
 
(30) Bolla, G.; Nangia, A. Binary and ternary cocrystals of sulfa drug acetazolamide with pyridine carboxamides 
and cyclic amides. IUCrJ, 2016, 3, 152-160. 
 
(31) Bolla, G.; Chernyshev, V.; Nangia, A. Acemetacin cocrystal structures by powder X-ray diffraction. IUCrJ 
2017, 4, 206-214. 
 
(32) Osterberg, C. E.; Arif, A. M.; Richmond, T. G. Transition metal based reagents for molecular recognition: 
hydrogen bonding properties of tungsten(II) cis-amino halides. J. Am. Chem. Soc. 1988, 110, 6903-6904. 
 
(33) Bear, J. L.; Lifsey, R. S.; Chau, L. K.; Ahsan, M. Q.; Korp, J. D.; Chavan, M.; Kadish, K. M. Structural, 
spectroscopic, and electrochemical characterization of tetrakis-µ-(2-pyrrolidinonato)-dirhodium(II) and tetrakis-
µ-(δ-valerolactamato)-dirhodium(II). J. Chem. Soc., Dalton Trans. 1989, 93-100. 
 
(34) Munhoz, C.; Isolani, P. C.; Vicentini, G.; Zukerman-Schpector, J. Lanthanide perrhenate complexes with δ-
valerolactam: synthesis, characterization and structure. J. Alloys Compd. 1998, 275, 782-784. 
 
(35) Marchetti, F.; Pampaloni, G.; Zacchini, S. Lactam/MoCl5 interaction in CH2Cl2: synthesis and X-ray 
characterization of protonated δ-valerolactam salts. RSC Advances 2013, 3, 10007-10013. 
 
(36) Wang, Y.; Ma, P.; Niu, J. Organic–inorganic hybrid rare earth complexes based on polymolybdates with 
intrinsic photosensitive properties. J. Chem. Soc., Dalton Trans. 2015, 44, 4679-4682. 
 
(37) http://www.fluorochem.co.uk/Products/Search?searchType=P&searchText=valerolactam, accessed on 1st 
Nov 2018  
 
(38) Martinez-Mayorga, K.; Juaristi, E.; Cuevas, G. Manifestation of stereoelectronic effects on the calculated 
carbon-hydrogen bond lengths and one-bond 1JC-H NMR coupling constants. Relative acceptor ability of the 
carbonyl (C=O), thiocarbonyl (C=S), and methylidene (C=CH2) groups toward C-H donor bonds. J. Org. Chem. 
2004, 69, 7266-7276. 
 
(39) Treschanke, L.; Rademacher, P. Electronic structure and conformational properties of the amide linkage: Part 
1. Geometric and electronic structure of lactams as determined by MNDO calculations. J. Mol. Struct. (Theochem) 
1985, 122, 35-45. 
 
(40) Kuze, N.; Funahashi, H.; Ogawa, M.; Tajiri, H.; Ohta, Y.; Usami, T.; Sakaizumi, T.; Ohashi, O. Microwave 
Spectrum and Molecular Conformation of δ-Valerolactam. J. Mol. Spectr. 1999, 198, 381-386. 
 
(41) Bird, R. G.; Vaquero-Vara, V.; Zaleski, T. P.; Pate, B. H.; Pratt, D. W. Chirped-pulsed FTMW spectra of 
valeric acid, 5-aminovaleric acid, and δ-valerolactam: A study of amino acid mimics in the gas phase. J. Mol. 
Spectr. 2012, 280, 42-46. 
 
Page 11 of 13
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
12 
(42) Ibberson, R. M.; Telling, M. T. F.; Parsons, S. Crystal Structures and Glassy Phase Transition Behavior of 
Cyclohexene. Cryst. Growth Des. 2008, 8, 512-518.  
 
(43) Carvalho, L. R. F.; Zinner, L. B.; Vicentini, G.; Bombieri, G.; Benetollo, F. Thermal study of δ-valerolactam 
complexes of lanthanoid perchlorates. Inorg. Chim. Acta 1992, 191, 49-56. 
 
(44) Kahn, R.; Fourme, R.; Andre, D.; Renaud, M. Crystal structure of cyclohexane I and II. Acta Crystallogr. 
1973, B29, 131-138.  
 
(45) Yang, Q.-C.; Seiler, P.; Dunitz, J. D. β-Propiolactam (1-aza-2-cyclobutanone) at 170 K. Acta Crystallogr. 
1987, C43, 565-567. 
 
(46) Goddard, R.; Heinemann, O.; Kruger, C.; Magdo, I.; Mark, F.; Schaffner, K. A Low-Temperature Phase of 
2-Pyrrolidone. Acta Crystallogr. 1998, C54, 501-504. 
 
(47) Winkler, F. K.; Dunitz, J. D. Medium-ring compounds. XIX. Caprolactam: structure refinement. Acta 
Crystallogr. 1975, B31, 268-269.  
 
(48) Winkler, F. K.; Seiler, P. Enantholactam (7-heptanelactam), at 98 K. Acta Crystallogr. 1979, B35, 1920-
1922. 
 
(49) Winkler, F. K.; Dunitz, J. D. Medium-ring compounds. XXII. Caprylolactam. Acta Crystallogr. 1975, B31, 
276-278. 
 
(50) Winkler, F. K.; Dunitz, J. D. Medium-ring compounds. XXIV. Pelargolactam. Acta Crystallogr. 1975, B31, 
281-283. 
 
(51) Drawz, S. M.; Bonomo, R. A. Three Decades of β-Lactamase Inhibitors. Clin. Microbiol. Rev. 2010, 23, 
160–201.  
 
(52) Imming, P.; Klar, B.; Dix, D. Hydrolytic Stability versus Ring Size in Lactams:  Implications for the 
Development of Lactam Antibiotics and Other Serine Protease Inhibitors. J. Med. Chem. 2000, 43, 4328-4331. 
 
(53) Romers, C.; Rutten, E. W. M.; van Driel, C. A. A.; Sanders, W. W. The conformation of non-aromatic ring 
compounds. XXVIII. The crystal structure of α-chloro-δ-valerolactam. Acta Crystallogr. 1967, 22, 893-899. 
 
(54) Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112-122. 
 
(55) Hübschle, C. B.; Sheldrick, G. M.; Dittrich, B. ShelXle: a Qt graphical user interface for SHELXL. J. Appl. 
Crystallogr. 2011, 44, 1281-1284. 
 
  
Page 12 of 13
ACS Paragon Plus Environment
Crystal Growth & Design
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13 
For Table of Contents Use Only. 
 
The missing link in the homologous series of lactams: the X-ray structure of 
valerolactam 
 
Christian Weck, Elisa Nauha, Tobias Gruber 
 
 
 
 
 
 
For the small and medium-sized parent 
lactams the X-ray structures are well known 
for many years – except for the ‘missing 
link’ valerolactam, i.e. the 6-membered 
lactam. Its X-ray structure is described here 
for the first time stimulating a comparative 
discussion of the homologous series of 
lactams.  
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